10:15 AM EDT, 05/29/2025 (MT Newswires) -- Iradimed ( IRMD ) said Thursday its magnetic resonance imaging-compatible MRidium 3870 IV infusion pump system received 510(k) clearance from the US Food and Drug Administration.

The MRidium 3870 is equipped with a non-magnetic ultrasonic pump motor, non-interfering radiofrequency emissions, and non-ferrous components, enabling safe operation in high-magnetic-field MRI environments, the company said.

IRadimed ( IRMD ) said it plans to begin rolling out the device to select healthcare facilities in Q4, with full commercial distribution expanding throughout 2026.

Shares of IRadimed ( IRMD ) were up more than 8% in recent Thursday trading.

Price: 56.00, Change: +4.34, Percent Change: +8.40